These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 25440760

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Targeting NPRL2 to enhance the efficacy of Olaparib in castration-resistant prostate cancer.
    Chen X, Chen Z, Zheng B, Tang W.
    Biochem Biophys Res Commun; 2019 Jan 08; 508(2):620-625. PubMed ID: 30522863
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Lo C, Lai TY, Yang JS, Yang JH, Ma YS, Weng SW, Lin HY, Chen HY, Lin JG, Chung JG.
    Melanoma Res; 2011 Aug 08; 21(4):267-73. PubMed ID: 21734530
    [Abstract] [Full Text] [Related]

  • 25. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D, Tao T, Xu B, Chen S, Liu C, Zhang L, Lu K, Huang Y, Jiang L, Zhang X, Huang X, Zhang L, Han C, Chen M.
    Biochem Biophys Res Commun; 2014 Feb 28; 445(1):151-6. PubMed ID: 24491557
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. TP53INP1 as new therapeutic target in castration-resistant prostate cancer.
    Giusiano S, Baylot V, Andrieu C, Fazli L, Gleave M, Iovanna JL, Taranger-Charpin C, Garcia S, Rocchi P.
    Prostate; 2012 Sep 01; 72(12):1286-94. PubMed ID: 22213058
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation.
    Thelen P, Heinrich E, Bremmer F, Trojan L, Strauss A.
    Prostate; 2013 Nov 01; 73(15):1699-709. PubMed ID: 23868789
    [Abstract] [Full Text] [Related]

  • 32. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ, Johnson M, Koterba K, Herynk MH, Uehara H, Gallick GE.
    Clin Cancer Res; 2003 Nov 01; 9(14):5161-70. PubMed ID: 14613995
    [Abstract] [Full Text] [Related]

  • 33. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
    Mi YY, Ji Y, Zhang L, Sun CY, Wei BB, Yang DJ, Wan HY, Qi XW, Wu S, Zhu LJ.
    Cell Death Dis; 2023 Jan 28; 14(1):67. PubMed ID: 36709328
    [Abstract] [Full Text] [Related]

  • 34. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX.
    Mol Immunol; 2009 Sep 28; 46(15):2876-84. PubMed ID: 19643479
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH, Lu MH, Wang JC, Wang F, Ding WF, Wang YG, Ju SQ, Wang HM.
    Zhonghua Zhong Liu Za Zhi; 2013 Apr 28; 35(4):249-55. PubMed ID: 23985251
    [Abstract] [Full Text] [Related]

  • 38. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
    Kim IJ, Kang TW, Jeong T, Kim YR, Jung C.
    Int J Oncol; 2014 Aug 28; 45(2):869-76. PubMed ID: 24898171
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.
    Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C, Chen J, Liu Z, Huang G, Li LC, Sun Y.
    J Cell Physiol; 2014 Jul 28; 229(7):834-44. PubMed ID: 24243035
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.